Jia-Yi Li
51 – 100 of 104
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
(
- Contribution to journal › Article
- 2013
-
Mark
Dendritic Spine Instability Leads to Progressive Neocortical Spine Loss in a Mouse Model of Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Axonopathy in Huntington's disease.
(
- Contribution to journal › Scientific review
-
Mark
Active zone protein expression changes at the key stages of cerebellar cortex neurogenesis in the rat
(
- Contribution to journal › Article
-
Mark
NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
- 2012
-
Mark
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells
(
- Contribution to journal › Article
-
Mark
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
2012) In European Journal of Pharmacology(
- Contribution to journal › Article
- 2011
-
Mark
Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
(
- Contribution to journal › Article
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Neurogenesis In The R6/2 Mouse Model Of Huntington'S Disease Is Impaired At The Level Of Neurod1
(
- Contribution to journal › Article
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Foxa2 and Nurr1 Synergistically Yield A9 Nigral Dopamine Neurons Exhibiting Improved Differentiation, Function, and Cell Survival
(
- Contribution to journal › Article
-
Mark
Characterization of Lewy Body Pathology in 12-and 16-Year Old Intrastriatal Mesencephalic Grafts Surviving in a Patient with Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Are synucleinopathies prion-like disorders?
(
- Contribution to journal › Article
-
Mark
GABAergic Differentiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2, NeuroD1, and NeuroD2.
(
- Contribution to journal › Article
-
Mark
A simple method for large-scale generation of dopamine neurons from human embryonic stem cells.
(
- Contribution to journal › Article
- 2009
-
Mark
Divalent metal transporter 1 is involved in amyloid precursor protein processing and A{beta} generation.
(
- Contribution to journal › Article
-
Mark
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis.
(
- Contribution to journal › Article
-
Mark
Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis.
(
- Contribution to journal › Article
- 2008
-
Mark
From bench to bed: the potential of stem cells for the treatment of Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, MSX1, Ngn2, and Pitx3.
2008) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 28(14). p.3644-3656(
- Contribution to journal › Article
-
Mark
Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20.
(
- Contribution to journal › Article
-
Mark
Research in motion: the enigma of Parkinson's disease pathology spread.
(
- Contribution to journal › Scientific review
-
Mark
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.
(
- Contribution to journal › Article
-
Mark
Critical issues of clinical human embryonic stem cell therapy for brain repair.
(
- Contribution to journal › Article
- 2007
-
Mark
Restorative cell therapy for Parkinson's disease: A quest for the perfect cell
(
- Contribution to journal › Scientific review
-
Mark
"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells.
(
- Contribution to journal › Article
-
Mark
Axonal transport of neuropeptides: Retrograde tracing study in live cell cultures of rat sympathetic cervical ganglia.
(
- Contribution to journal › Article
-
Mark
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Adult neurogenesis in neurodegenerative diseases
2007) p.445-445(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2006
-
Mark
Cholinergic neuronal defect without cell loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Laminin {alpha}1 chain improves laminin {alpha}2 chain deficient peripheral neuropathy.
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y-2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats
(
- Contribution to journal › Article
-
Mark
Failure of transdifferentiation of adult hematopoietic stem cells into neurons.
(
- Contribution to journal › Article
-
Mark
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation
(
- Contribution to journal › Article
-
Mark
Transplantation in Parkinson's disease: The future looks bright.
(
- Contribution to journal › Article
- 2005
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
(
- Contribution to journal › Article
-
Mark
Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes.
(
- Contribution to journal › Article
-
Mark
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.
(
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Stem cell-based therapy for Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
-
Mark
Synaptic dysfunction in Huntington's disease: a new perspective
(
- Contribution to journal › Scientific review